Do acute ischemic stroke patients receive the right treatment in non-stroke units? by Adam, D. et al.
Romanian Neurosurgery  |  Volume XXXI  |  Number 3 |  2017  |  July-September 
 
Article 
 
Do acute ischemic stroke patients receive the 
right treatment in non-stroke units?  
 
D. Adam, Gina Burduşa, D. Iftimie 
ROMANIA 
 
 
 
DOI: 10.1515/romneu-2017-0044 
 
 
 
 
 
 
Romanian Neurosurgery (2017) XXXI 3: 263 - 271 | 263 
 
 
 
 
 
 
 
DOI: 10.1515/romneu-2017-0044   
Do acute ischemic stroke patients receive the right 
treatment in non-stroke units? 
D. Adam1,2, Gina Burduşa1, D. Iftimie1 
1Department of Neurosurgery, “Saint Pantelimon” Clinical Emergency Hospital, Bucharest, ROMANIA 
2“Carol Davila” University of Medicine and Pharmacy, Bucharest, ROMANIA 
 
Abstract: Background: Modern treatment of acute ischemic stroke includes 
thrombolysis and thrombectomy performed for eligible patients in specialized stroke 
centers. However, a number of patients are admitted in Neurosurgical or Intensive Care 
Departments of emergency hospitals, units where routine treatment strategies are 
applied. Objective: To evaluate the management of patients admitted in these 
departments that do not benefit from thrombolytic or endovascular treatment. Methods: 
A retrospective analysis was performed, including all patients admitted to the 
Neurosurgery Department and Intensive Care Unit (ICU) of the “St. Pantelimon” 
Clinical Emergency Hospital with the primary diagnosis of acute ischemic stroke in the 
year 2016. The following data was retrospectively collected: patient age and sex, 
comorbidities, risk factors for ischemic stroke, level of consciousness at admission, 
neurological deficits, stroke location, blood glucose levels, interval from stroke onset to 
admission, treatment and discharge status. Results: In 2016, 63 patients with primary 
diagnosis of acute ischemic stroke confirmed by head CT scan were admitted in our 
hospital. None presented indication for decompressive craniectomy. Over a half of them 
(57,14%) were comatose. The majority of patients admitted to the ICU (76,47%) received 
glucose 10% infusions in the first 24 hours from admission, despite increased blood 
glucose levels at admission. A number of 38 (60,32%) of these patients died. Conclusions: 
Patients with acute ischemic stroke should be treated in stroke units with proper 
equipment and specialists. National public health institutions should take the necessary 
measures in order to ensure that patients get to the best facility in order to receive the 
right therapy in the right amount of time. 
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Introduction 
Stroke is the third cause of death and the 
first cause of neurological disability worldwide 
(1). In the European Union, 1 million people 
develop an ischemic stroke yearly and it is 
estimated that in 2020 the total prevalence will 
be 6,2% of the total population. Over 4,7 
million strokes occur worldwide every year. 
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During their lifetime, approximately 1 in 6 
individuals will develop a stroke (2).  
The management of ischemic stroke has 
evolved from treatment of risk factors and 
management of complications, to i.v., i.a. 
thrombolysis or thrombectomy for eligible 
patients, which could be supplemented in the 
future with neuroprotective and stem cell 
treatment. 
Current treatment options are performed 
in units specialized in endovascular treatment, 
considered “standard of care” for patients with 
ischemic disabilitating stroke. These new 
therapies are performed by neurologists and 
neurointerventional radiologists during the 
opportunity window of up to 6 hours from 
stroke onset or from time last seen well. 
Not all patients with ischemic stroke are 
admitted to medical centers specialized in 
their treatment and only a part of them arrive 
during the therapeutic time window. 
In our emergency hospital, patients with 
neurological deficits arrive by ambulance in 
the Emergency Department, where they are 
diagnosed and admitted to the Neurosurgical 
Department or Intensive Care Unit (ICU). 
The aim of this study is to evaluate the 
management of patients admitted in these 
departments that do not benefit from 
thrombolytic or endovascular treatment. 
Material and methods 
This study encompasses all patients 
admitted to the Neurosurgery Department 
and ICU of the “St. Pantelimon” Clinical 
Emergency Hospital in the year 2016 with the 
primary diagnosis of acute ischemic stroke. 
All patients were brought in by ambulance 
to the Emergency Department and were 
admitted with the diagnosis of acute ischemic 
stroke, based upon the neurological 
examination and emergency head CT scan. If 
the initial head CT scan was inconclusive, the 
investigation was repeated after 12-24 hours. 
Conscious patients were hospitalized in the 
Neurosurgical Department while the ones that 
were comatose or presented decompensated 
comorbidities were admitted in the ICU. 
All patients’ medical records were reviewed 
and the following data was collected: patient 
age and sex, comorbidities, risk factors for 
ischemic stroke, level of consciousness at 
admission, neurological deficits, stroke 
location, blood glucose levels, interval from 
stroke onset to admission, treatment and 
discharge status. 
In our hospital, thrombolytic or 
endovascular treatment is not available. 
In the case of comatose patients, 
management goals were sustaining vital 
functions, stabilization of paraclinical 
parameters and treatment of risk factors and 
comorbidities. We have particularly evaluated 
the outcome of patients and the treatment they 
received during hospitalization. 
Patients with a favorable neurological 
evolution, meaning alleviation or stabilization 
of motor deficits were transferred to a 
neurological recovery department or 
discharged at home. 
Results 
In the year 2016, 63 patients with a primary 
diagnosis of acute ischemic stroke confirmed 
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by head CT scan arrived in the emergency 
room and were admitted in our hospital. 
The majority of patients were over 60 years 
old (58 cases, 92,06%), without a significant 
difference regarding gender distribution 
(Table 1). 
Regarding comorbidities, most patients 
presented high blood pressure (55; 87,3%), 
atrial fibrillation (47; 74,6%) and diabetes 
mellitus (24; 38,1%). 
At time of presentation 36 patients were 
comatose (57,14%) and the remaining 27 
(42,86%) were conscious (GCS≥9). 
On the basis of neurological deficits 
(hemiparesis, aphasia, seizures), 52 (82,54%) 
developed an ischemic stroke in the anterior 
circulation, while vertigo and balance 
disorders suggested the stroke’s location in the 
posterior circulation in 16 cases (25,39%). 
The presumptive diagnosis of ischemic 
stroke and its location were confirmed by 
cerebral CT scan that showed loss of grey-
white matter differentiation, an area of 
hypodensity and/or hyperattenuation of a 
blood vessel. 
TABEL I 
Patient characteristics 
 Number Percentage 
Total number 63  
Gender   
 Male 29 46,03% 
Female 34 53,97% 
Age group   
30-39 1 1,59% 
40-49 2 3,17% 
50-59 2 3,17% 
60-69 16 25,40% 
70-79 22 34,92% 
80-89 14 22,22% 
90-99 6 9,52% 
Comorbidities   
High blood pressure 55 87,30% 
Atrial fibrillation 47 74,60% 
Diabetes mellitus 24 38,10% 
Congestive heart failure 22 34,92% 
Hypercholesterolemia and obesity 13 20,63% 
GCS at presentation   
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3 - 8 36 57,14% 
9 - 15 27 42,86% 
Admission department   
Neurosugery 19 30,16% 
Intensive Care Unit 44 69,84% 
Neurological deficits   
Hemiparesis 35 55,56% 
Aphasia 17 26,98% 
Balance disorders 16 25,39% 
Coma 36 57,14% 
Seizures 3 4,76% 
Stroke location   
Anterior circulation 52 82,54% 
• Unilateral MCA 40 63,49% 
• Bilateral MCA 7 11,11% 
• Terminal ICA 2 3,17% 
Posterior circulation 13 20,63% 
Evolution   
Discharged at home 16 25,40% 
Transfered to neurological recovery department 9 14,28% 
Deceased 38 60,32% 
 
In only 29 patients the time interval 
between the stroke onset to admission could 
be established. Out of these, only 7 were 
admitted in less than 6 hours from symptoms’ 
onset. 
Although only 24 patients were previously 
diagnosed with diabetes mellitus, initial blood 
sugar levels were above the normal range in 53 
patients of which 15 were admitted in the 
Neurosurgery Department and 38 in the 
Intensive Care Unit. 
The 38 cases in the ICU with increased 
blood glucose levels, in addition to support of 
vital functions, routinely received glucose 10% 
infusion in 26 cases in the first day of 
hospitalization (76,47%), 5 (14,71%) from the 
second day, 2 (5,88%) from the third day and 
1 (2,94%) from the fourth. 
Out of the 63 admitted patients, a number 
of 38 (60,32%) patients died (12 male and 26 
female). 
Out of the 44 patients admitted in the ICU, of 
which 36 were comatose (GCS 3=12, GCS 4=7, 
GCS 5=2, GCS 6 = 9, GCS 7 = 4, GCS 8 = 2) and 
38 had increased blood sugar levels, 34 received 
treatment with glucose 10% and 38 died. 
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Only 6 patients from to the Intensive Care 
Unit group survived, that presented normal 
blood sugar levels on admission. 
Among the 25 patients admitted in the 
Neurosurgery Department, only 5 received 
treatment with glucose initiated in the third 
and fourth day of hospitalization. All these 
patients presented a favorable evolution and 
were transferred to neurological recovery 
departments. 
Patients that died in the ICU were in 
critical condition at admission (various 
degrees of coma). None of these cases 
presented indication for decompressive 
craniectomy. 
Discussion 
Stroke is defined as an acute disruption of 
cerebral function of a presumed vascular cause 
that produces a neurological deficit which lasts 
more than 24 hours or leads to death in the 
first 24 hours. 
Ischemic stroke is caused by absence of 
blood flow in a part or the entire brain, that 
induces nerve cells’ deprivation of glucose and 
oxygen. The most frequent cause of ischemic 
stroke is occlusion of a cerebral artery, but it 
can also be induced by deprivation of oxygen 
only (in the case of a cardio-respiratory arrest) 
or glucose deprivation only as, in the case of 
diabetic patients treated with insulin 
overdoses. 
Patients with ischemic stroke present, on 
admission to hospital, in up to two thirds of 
cases, increased blood sugar levels. (3) 
Hyperglycemia is defined as a blood glucose 
concentration greater that 115 mg/dl (6,1 
mmol/l).  
Between 20% and 50% of acute stroke 
patients presented with hyperglycemia at 
admission in the studies of Gray and Toni (4, 
5). 
Hyperglycemia in these cases can be the 
result of: 
•previously diagnosed diabetes mellitus 
patients, that represent 8-20% of stroke 
patients, with poor glycemic control 
•patients with undiagnosed diabetes 
mellitus represent 5-28% (6, 7) 
•as a result of early hormonal response to 
cerebral ischemia (stress response) (8, 9). 
Hyperglycemia enhances acidosis and 
ischemic neuronal damage by facilitating free 
radical formation, activating pH-dependent 
endonucleases, enhancing glutamate release 
and excessive influx of calcium, with the end 
result of neuronal death (10).  
Hyperglycemia accelerates the ischemic 
process in stroke. 
In stroke patients, hyperglycemia is 
associated with larger infarct volumes, poor 
functional outcome, increased stroke 
mortality independent of age, stroke severity 
or stroke type. (11–13)  
Our in-hospital mortality is very high 
(60.32%), by comparison with 7,8% reported 
by Ihara in a recent study performed in Japan 
(14). The majority of admitted stroke patients 
were outside the opportunity window for 
thrombolysis/thrombectomy and already in 
critical condition (comatose), which can 
explain the high rate of in-hospital mortality. 
In addition, most of them received a 
potentially harmful treatment, consisting of 
glucose 10% infusions administered in the first 
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24 hours from stroke onset, to patients that 
were already hyperglycemic. 
In Stead et al’s study, ischemic stroke 
patients with hyperglycemia were 2,3 times 
more likely to be dead within 90 days, by 
comparison with those with normal glucose 
levels (15). 
In diabetic patients with ischemic stroke, 
the 30-day mortality rate is 2 fold higher. (11) 
Hyperglycemia has been suggested as an 
independent risk factor for the hemorrhagic 
conversion of stroke after administration of 
thrombolytic therapy. 
In the setting of stroke, euglycemia should 
be the clinical goal. Glucose levels should be 
tested repeatedly and if it is higher than 140-
180 mg/dl, treatment with insulin is indicated 
(1).  
Insulin is administered subcutaneously 
because intravenous administration increases 
the risk of hypoglycemia. 
Scott et al (3) infused 500 ml of 10% 
dextrose with 16 U insulin and 20 mmol 
potassium chloride (GKI) in mild to moderate 
hyperglycemia following acute stroke and 
considered it a pragmatic intervention which 
effectively lowers plasmatic glucose levels 
within the normal range. 
However there is limited evidence as to 
whether reduction of glucose levels in acute 
ischemic stroke improves patient outcome. 
European Stroke Initiative (EUSI) 
guidelines consider that routine use of insulin 
infusion regimes in patients with moderate 
hyperglycemia and acute ischemic stroke 
cannot be recommended. (16) Blood glucose 
levels exceeding 180 mg/dl have to be reduced. 
Maintaining a blood glucose level of 140 mg/dl 
seems to be reasonable, as more aggressive 
targets may worsen outcome. (17) 
The use of intravenous saline and 
avoidance of glucose solutions in the first 24 
hours after stroke is common practice in 
stroke units. (18) 
In our study, 36 patients were in a critical 
condition at presentation (GCS<8) and 38 
presented hyperglycemia. 
The administration of 10% glucose to 
ischemic stroke patients with hyperglycemia 
in the first 24 hours is harmful to nerve cells, 
hastens the expansion of the stroke’s core in 
the penumbra, enlarges the infarction zone 
and increases the rate of mortality. 
A decompressive craniectomy could have 
been considered only in the case of two 
patients with malignant infarction, but their 
critical condition contraindicated the 
potential surgical intervention. 
Stroke care has entered into a new era. 
In order to prevent persistent brain 
damage in an acute ischemic stroke, early 
restoration of cerebral blood flow is necessary. 
In 1996 the US FDA approved intravenous 
thrombolysis with rt-PA for treatment of acute 
ischemic stroke. Intravenous rt-PA has 
become the “holy grail” of acute stroke 
treatment and is still the standard treatment 
for eligible stroke patients presenting within 
4,5 hours after symptom onset. 
However, it may produce recanalization and 
reperfusion in 5-10% of patients. Reperfusion 
rates are higher in the M2 segment of the MCA, 
in small vessels and in microvascular structures. 
In contrast, it is ineffective in the majority of 
patients with large thrombi and in patients with 
large vessel occlusions. 
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Intravenous thrombolysis has a limited 
effectiveness in large vessel occlusion. 
Mechanical thrombectomy determined 
high rates of recanalization in proximal artery 
occlusion. 
When a cerebral vessel is obstructed, there 
are two compartments in its respective 
territory: core and penumbra. 
Inside the core, brain tissue is already dead, 
while in the penumbra neurons are 
structurally intact, only their functionality 
being affected. The goal of stroke treatment is 
to save the penumbra because the center of the 
infarction extends in the penumbra, while the 
latter shrinks progressively until the entire 
vascular territory becomes infarcted. 
The infarction’s evolution is dependent on 
the occlusion time and the state of collateral 
blood flow. In some patients with poor 
collateral circulation, the progression is faster, 
while in the case of good collateral flow, the 
progression is slower (19). 
Khartri et al state that every 30 minutes of 
reperfusion delay is associated with a relative 
10% reduction of good outcome probability 
(mRS = 0-2) (20). 
Endovascular mechanical thrombectomy 
is an important advance for those patients with 
large vessel occlusion and stroke located in the 
anterior circulation. 
The criteria presented in the new 
guidelines for mechanical thrombectomy are: 
•pre-stroke mRS score = 0-1 
•acute ischemic stroke that received i.v. t-
PA within 4,5 hours of symptom onset. 
•causative occlusion of the internal carotid 
artery or proximal (M1) middle cerebral artery 
(MCA) 
•age of 18 years or older 
•NIHSS score ≥ 6 
•Alberta Stroke Program Early CT 
(ASPECTS) score ≥ 6 
•treatment that can be initiated within 6 
hours of symptom onset (21) 
Selection of patients for endovascular 
treatment of acute ischemic stroke can be 
performed with the help of CT or MRI 
imaging. 
Diffusion weighted magnetic resonance 
imaging is the gold standard for estimating the 
ischemic core. It provides full brain coverage 
and detects smaller lesions (22).  
Perfusion CT evaluates cerebral blood 
volume and cerebral blood flow, but does not 
provide any information in cases with critical 
blood flow in preceding hours, that remitted 
with subsequent reperfusion. 
The continued evolution of various 
therapies and technologies (such as aspiration 
and stent retrievers) will play an important 
role in the successful treatment of stroke 
patients. 
Stroke patients have to be treated as quickly 
as possible. Today, the time windows has been 
extended beyond 6 hours from time last know 
well. The DAWN trial has shown a 73% 
reduction in disability in stroke patients 
treated within 24 hours. (23) 
Conclusions 
A part of patients with ischemic stroke are 
admitted to emergency hospitals in 
Neurosurgical or Intensive Care Departments, 
units that are not all specialized in performing 
thrombolysis or thrombectomy. 
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In this retrospective study we have 
analyzed the treatment received by these 
patients, that frequently included glucose 10% 
infusions, indicated from the first day of 
hospitalization even in the case of 
hyperglycemia and we have found a high rate 
of mortality in these cases. 
Raising awareness upon the fact that 
glucose infusions administered to 
hyperglycemic patients in the first 24 hours 
after stroke onset could have a negative effect 
on their outcome and should not be prescribed 
routinely is of significant importance. This 
could be achieved with the help of CME 
courses for all physicians that are currently 
involved in the management of stroke patients. 
Patients with acute ischemic stroke must be 
treated in stroke units, with proper equipment 
and specialists, where they should arrive in 
good time in order to benefit from a modern, 
efficient treatment provided by neurologists or 
neurointerventional radiologists. An increase 
in number and capacity of these medical units 
specialized in the treatment of ischemic stroke 
is imperative. 
Results of our analysis are intended to 
correct routine treatment strategies of stroke 
patients and to raise the awareness of national 
public health institutions. The necessary 
measures should be taken in order to ensure 
that patients get to the best facility in order to 
receive the right therapy in the right amount of 
time. 
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